AVEO Pharmaceuticals Statistics Share Statistics AVEO Pharmaceuticals has 0
shares outstanding. The number of shares has increased by 0.34%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0.34% Shares Change (QoQ) 0.3% Owned by Institutions (%) n/a Shares Floating 34.34M Failed to Deliver (FTD) Shares 250 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 725.82K, so 0% of the outstanding
shares have been sold short.
Short Interest 725.82K Short % of Shares Out n/a Short % of Float 2.39% Short Ratio (days to cover) 1.23
Valuation Ratios The PE ratio is -2.64 and the forward
PE ratio is null.
AVEO Pharmaceuticals's PEG ratio is
-0.36.
PE Ratio -2.64 Forward PE n/a PS Ratio 4.15 Forward PS n/a PB Ratio 3.52 P/FCF Ratio -2.82 PEG Ratio -0.36
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AVEO Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.59,
with a Debt / Equity ratio of 0.
Current Ratio 5.59 Quick Ratio 5.5 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 12.25
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $341K Profits Per Employee $-536.62K Employee Count 114 Asset Turnover 0.37 Inventory Turnover 2.86
Taxes Income Tax 7.83M Effective Tax Rate -14.68%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so AVEO Pharmaceuticals's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 14.9 200-Day Moving Average 9.19 Relative Strength Index (RSI) 73.1 Average Volume (20 Days) 564,056
Income Statement In the last 12 months, AVEO Pharmaceuticals had revenue of 38.87M
and earned -61.17M
in profits. Earnings per share was -1.78.
Revenue 38.87M Gross Profit 34.14M Operating Income -49.55M Net Income -61.17M EBITDA -57.39M EBIT -57.39M Earnings Per Share (EPS) -1.78
Full Income Statement Balance Sheet The company has 70.54M in cash and 11K in
debt, giving a net cash position of 70.53M.
Cash & Cash Equivalents 70.54M Total Debt 11K Net Cash 70.53M Retained Earnings -674.55M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -57.26M
and capital expenditures 0, giving a free cash flow of -57.26M.
Operating Cash Flow -57.26M Capital Expenditures n/a Free Cash Flow -57.26M FCF Per Share -1.67
Full Cash Flow Statement Margins Gross margin is 87.81%, with operating and profit margins of -127.47% and -157.37%.
Gross Margin 87.81% Operating Margin -127.47% Pretax Margin -137.22% Profit Margin -157.37% EBITDA Margin -147.62% EBIT Margin -127.47% FCF Margin -147.29%
Dividends & Yields AVEO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for AVEO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 20, 2020. It was a
backward
split with a ratio of 1:10.
Last Split Date Feb 20, 2020 Split Type backward Split Ratio 1:10
Scores Altman Z-Score n/a Piotroski F-Score n/a
